Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France
Richard Wheeler
Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France; Tumour Immunology and Immunotherapy, Institut Gustave Roussy, Villejuif, France
Ala-Eddine Deghmane
Unité des Infection Bactériennes Invasives, Institut Pasteur, Paris, France
Ignacio Santecchia
Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France; Universté Paris Descartes, Sorbonne Paris Cité, Paris, France
Ryan E Schaub
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
Samia Hicham
Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France
Maryse Moya Nilges
Unité Technologie et Service BioImagerie Ultrastructural, Institut Pasteur, Paris, France
Christian Malosse
Unité Technologie et Service Spectrométrie de Masse pour la Biologie, Institut Pasteur; UMR 3528, CNRS 75015, Paris, France
Julia Chamot-Rooke
Unité Technologie et Service Spectrométrie de Masse pour la Biologie, Institut Pasteur; UMR 3528, CNRS 75015, Paris, France
Ahmed Haouz
Plate-forme de Cristallographie-C2RT, Institut Pasteur; UMR3528, CNRS 75015, Paris, France
Joseph P Dillard
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
William P Robins
Department of Microbiology, Harvard Medical School, Boston, United States
Muhamed-Kheir Taha
Unité des Infection Bactériennes Invasives, Institut Pasteur, Paris, France
Ivo Gomperts Boneca
Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France
Lytic transglycosylases (LT) are enzymes involved in peptidoglycan (PG) remodeling. However, their contribution to cell-wall-modifying complexes and their potential as antimicrobial drug targets remains unclear. Here, we determined a high-resolution structure of the LT, an outer membrane lipoprotein from Neisseria species with a disordered active site helix (alpha helix 30). We show that deletion of the conserved alpha-helix 30 interferes with the integrity of the cell wall, disrupts cell division, cell separation, and impairs the fitness of the human pathogen Neisseria meningitidis during infection. Additionally, deletion of alpha-helix 30 results in hyperacetylated PG, suggesting this LtgA variant affects the function of the PG de-O-acetylase (Ape 1). Our study revealed that Ape 1 requires LtgA for optimal function, demonstrating that LTs can modulate the activity of their protein-binding partner. We show that targeting specific domains in LTs can be lethal, which opens the possibility that LTs are useful drug-targets.